Skip to main content

Want a detailed portfolio tracker?

Arvinas (ARVN) P/E (2018 - 2026)

Arvinas (ARVN) P/E from Oct 1, 2018 to Jun 3, 2026. The TTM Arvinas (ARVN) P/E is -2.34. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arvinas (ARVN)

YearP/EChange
2026-2.34-75.15%
2025-9.43+42.71%
2024-6.61-11.65%
2023-7.48+3.90%
2022-7.20-67.12%
2021-21.89-26.86%
2020-29.93+51.92%
2019-19.70+150.48%
2018-7.87N/A

Comparison Arvinas (ARVN) P/E with competitors

Arvinas (ARVN) P/E is -2.34.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.10-104.36%
ENLVEnlivex Therapeutics Ltd0.15-106.41%
FGENFibroGen Inc0.24-110.24%
TRAWTraws Pharma Inc0.47-120.18%
FBIOFortress Biotech Inc0.71-130.13%
CHRSCoherus Biosciences Inc0.98-141.74%
ORMPOramed Pharmaceuticals Inc1.47-162.88%
AGENAgenus Inc2.05-187.42%
VIVSVivoSim Labs Inc2.54-208.22%
INVAInnoviva Inc3.19-236.08%
CRMDCorMedix Inc3.65-255.59%
ABEOAbeona Therapeutics Inc4.20-279.46%
VXRTVaxart Inc4.26-281.88%
CVACCureVac N.V.4.45-289.73%
SRPTSarepta Therapeutics Inc4.62-297.35%
GLPGGalapagos NV4.86-307.36%
RIGLRigel Pharmaceuticals4.92-309.95%
ZVRAZevra Therapeutics Inc4.97-312.28%
ABUSArbutus Biopharma Corp5.69-343.00%
CGENCompugen Ltd7.38-415.13%
AUPHAurinia Pharmaceuticals Inc9.25-494.83%
ACADAcadia Pharmaceuticals Inc9.59-509.20%
OMEROmeros Corporation9.88-521.81%
PLXProtalix BioTherapeutics Inc9.91-522.90%
SPROSpero Therapeutics Inc10.73-558.14%
ADMAAdma Biologics Inc11.33-583.57%
SVASinovac Biotech Ltd11.44-588.07%
TBPHTheravance Biopharma Inc11.78-602.61%
HRMYHarmony Biosciences Holdings Inc12.18-619.84%
TGTXTG Therapeutics Inc13.18-662.48%
INCYIncyte Corp13.38-671.12%
SABSSAB Biotherapeutics Inc14.06-699.96%
XOMAXOMA Corp14.95-737.84%
REGNRegeneron Pharmaceuticals Inc14.98-739.33%
PBYIPuma Biotechnology Inc15.05-742.33%
EXELExelixis Inc15.79-774.10%
NAGENiagen Bioscience Inc16.35-798.00%
CPRXCatalyst Pharmaceuticals Inc17.34-840.25%
MDXGMimedx Group Inc17.38-841.55%
ARGXArgen X SE23.07-1084.66%
HALOHalozyme Therapeutics Inc23.20-1090.17%
XOMAOXOMA Corp25.34-1181.68%
VRTXVertex Pharmaceuticals Inc25.66-1194.95%
XOMAPXOMA Corp25.67-1195.56%
CTMXCytomX Therapeutics Inc25.70-1196.75%
ASNDAscendis Pharma A/S26.35-1224.75%
RPRXRoyalty Pharma plc - Class A27.50-1273.46%
SLNOSoleno Therapeutics Inc29.02-1338.33%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1388.32%
BMRNBiomarin Pharmaceutical Inc37.51-1700.75%
APLSApellis Pharmaceuticals Inc39.02-1765.37%
KRYSKrystal Biotech Inc39.70-1794.23%
GMABGenmab40.20-1815.83%
ONCBeiGene Ltd67.03-2960.61%
TECHBio-Techne Corp68.59-3027.54%
VCELVericel Corp80.63-3541.14%
PHARPharming Group N.V.87.74-3844.62%
ALNYAlnylam Pharmaceuticals Inc124.93-5431.99%
TLXTelix Pharmaceuticals Ltd139.89-6070.33%
CORTCorcept Therapeutics Inc158.39-6859.83%